SEOUL,South Korea,Feb. 18,2025-- On February 17,VIVOZON Pharmaceutical announced that its non-opioid analgesic,UNAFRA Inj.,was approved on December 12,2024. (active ingredient: Opiranserin HCl),has r

Unveiling a More Accessible,State-of-the-Art AR Glasses Reference Model TOKYO,Feb. 18,2025-- Cellid Inc.,a developer of AR glasses displays and spatial recognition engines for next-generation devices

Almost 60% of survey respondents say increased costs and reduced profitability is a challenge,with about half finding cash flow and access to funding a challenge.

Two-thirds of survey respondents say increased costs and reduced profitability is a challenge,with over half seeing reduced customer spending and financial challenges.

TAIPEI,Feb. 17,2025-- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311,the world\'s first Apixaban oral dissolving film (ODF). The study confirmed that TAH

The Board of Directors of EQT AB ("EQT") has appointed Per Franzén as new CEO and Managing Partner,effective as of the Annual Shareholders\' Meeting on 27 May 2025. During this transi